Clearmind Medicine Inc (CMND)

Nov 20, 2025

Clearmind begins phase I/IIa trial for alcohol disorder drug at Hadassah - Investing.com Nigeria

Nov 20, 2025

Nov 20, 2025

What macro factors could drive Clearmind Medicine Inc. (CWY0) stock higherAnalyst Downgrade & Consistent Profit Trade Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

Can Clearmind Medicine Inc. (CWY0) stock survive global slowdownSell Signal & High Return Trade Opportunity Guides - newser.com

Nov 20, 2025

Nov 20, 2025

SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression - The Manila Times

Nov 20, 2025

Nov 20, 2025

SciSparc: Neurothera Labs Announces Israeli Patent - GlobeNewswire

Nov 20, 2025

Nov 20, 2025

Clearmind begins phase I/IIa trial for alcohol disorder drug at Hadassah By Investing.com - Investing.com South Africa

Nov 20, 2025

Nov 20, 2025

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site - The Manila Times

Nov 20, 2025

Nov 20, 2025

Clearmind Medicine files Israeli patent for depression treatment - MSN

Nov 20, 2025

Nov 20, 2025

Will Clearmind Medicine Inc. stock reach all time highs in 2025July 2025 EndofMonth & Real-Time Volume Triggers - newser.com

Nov 20, 2025

Nov 20, 2025

Clearmind Medicine announces results from Phase I/IIa trial of CMND-100 - MSN

Nov 20, 2025

Nov 19, 2025

Clearmind Medicine Inc. (CMND) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 19, 2025

Nov 19, 2025

Will Clearmind Medicine Inc. stock keep outperforming rivals2025 Technical Overview & Accurate Intraday Trade Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Can Clearmind Medicine Inc. (CWY0) stock double in coming yearsMarket Trend Review & Fast Exit Strategy with Risk Control - newser.com

Nov 19, 2025

Nov 19, 2025

Why Clearmind Medicine Inc. stock could benefit from AI revolutionMarket Growth Review & Weekly Return Optimization Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Strategies to average down on Clearmind Medicine Inc.Analyst Upgrade & Breakout Confirmation Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

How Clearmind Medicine Inc. stock performs after earningsJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com

Nov 19, 2025

Nov 19, 2025

How sentiment analysis helps forecast Clearmind Medicine Inc.Portfolio Profit Report & Safe Capital Growth Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression - Yahoo Finance

Nov 19, 2025

Nov 19, 2025

Neurothera Labs and Clearmind Medicine File Patent for Innovative Depression Treatment - TipRanks

Nov 19, 2025

Nov 19, 2025

Why Clearmind Medicine Inc. (CWY0) stock gets analyst attentionWeekly Market Report & Daily Chart Pattern Signals - newser.com

Nov 19, 2025

Nov 19, 2025

Neurothera Labs and Clearmind Medicine File Israeli Patent for Non-Hallucinogenic Depression Treatment - citybuzz

Nov 19, 2025

Nov 18, 2025

Clearmind Medicine (CMND) Delivers Positive AUD Trial Data Amid New Depression Patent – Nov. 18, 2025 - ts2.tech

Nov 18, 2025

Nov 18, 2025

Clearmind Medicine announces positive top-line results from first cohort of its FDA-approved Phase I/IIa clinical trial for alcohol use disorder - MarketScreener

Nov 18, 2025

Nov 18, 2025

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder - Yahoo Finance

Nov 18, 2025